187 related articles for article (PubMed ID: 31583707)
1. Inflammatory serum markers and risk and severity of prostate cancer: The PROCA-life study.
Stikbakke E; Richardsen E; Knutsen T; Wilsgaard T; Giovannucci EL; McTiernan A; Eggen AE; Haugnes HS; Thune I
Int J Cancer; 2020 Jul; 147(1):84-92. PubMed ID: 31583707
[TBL] [Abstract][Full Text] [Related]
2. Serum inflammatory markers in relation to prostate cancer severity and death in the Swedish AMORIS study.
Arthur R; Williams R; Garmo H; Holmberg L; Stattin P; Malmström H; Lambe M; Hammar N; Walldius G; Robinsson D; Jungner I; Van Hemelrijck M
Int J Cancer; 2018 Jun; 142(11):2254-2262. PubMed ID: 29322512
[TBL] [Abstract][Full Text] [Related]
3. Peripheral Inflammatory Biomarkers for Myocardial Infarction Risk: A Prospective Community-Based Study.
Wu Z; Huang Z; Jin W; Rimm EB; Lichtenstein AH; Kris-Etherton PM; Wu S; Gao X
Clin Chem; 2017 Mar; 63(3):663-672. PubMed ID: 28031418
[TBL] [Abstract][Full Text] [Related]
4. Prediagnostic circulating markers of inflammation and risk of prostate cancer.
Toriola AT; Laukkanen JA; Kurl S; Nyyssönen K; Ronkainen K; Kauhanen J
Int J Cancer; 2013 Dec; 133(12):2961-7. PubMed ID: 23754532
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory biomarkers as risk factors for future atrial fibrillation. An eleven-year follow-up of 6315 men and women: the Tromsø study.
Nyrnes A; Njølstad I; Mathiesen EB; Wilsgaard T; Hansen JB; Skjelbakken T; Jørgensen L; Løchen ML
Gend Med; 2012 Dec; 9(6):536-547.e2. PubMed ID: 23046763
[TBL] [Abstract][Full Text] [Related]
6. Prediagnostic serum inflammatory markers in relation to breast cancer risk, severity at diagnosis and survival in breast cancer patients.
Wulaningsih W; Holmberg L; Garmo H; Malmstrom H; Lambe M; Hammar N; Walldius G; Jungner I; Van Hemelrijck M
Carcinogenesis; 2015 Oct; 36(10):1121-8. PubMed ID: 26130675
[TBL] [Abstract][Full Text] [Related]
7. Comparison between high-sensitivity C-reactive protein (hs-CRP) and white blood cell count (WBC) as an inflammatory component of metabolic syndrome in Japanese.
Oda E; Kawai R
Intern Med; 2010; 49(2):117-24. PubMed ID: 20075574
[TBL] [Abstract][Full Text] [Related]
8. The prevalence and predictors of elevated C-reactive protein after a coronary heart disease event.
Munkhaugen J; Otterstad JE; Dammen T; Gjertsen E; Moum T; Husebye E; Gullestad L
Eur J Prev Cardiol; 2018 Jun; 25(9):923-931. PubMed ID: 29635941
[TBL] [Abstract][Full Text] [Related]
9. Relative Prognostic Value of Cardiac Troponin I and C-Reactive Protein in the General Population (from the Nord-Trøndelag Health [HUNT] Study).
Sigurdardottir FD; Lyngbakken MN; Holmen OL; Dalen H; Hveem K; Røsjø H; Omland T
Am J Cardiol; 2018 Apr; 121(8):949-955. PubMed ID: 29496193
[TBL] [Abstract][Full Text] [Related]
10. Association of inflammatory markers with colorectal cancer incidence in the atherosclerosis risk in communities study.
Prizment AE; Anderson KE; Visvanathan K; Folsom AR
Cancer Epidemiol Biomarkers Prev; 2011 Feb; 20(2):297-307. PubMed ID: 21217085
[TBL] [Abstract][Full Text] [Related]
11. Correlation of inflammatory serum markers with disease severity in patients with hidradenitis suppurativa (HS).
Hessam S; Sand M; Gambichler T; Bechara FG
J Am Acad Dermatol; 2015 Dec; 73(6):998-1005. PubMed ID: 26410359
[TBL] [Abstract][Full Text] [Related]
12. Elevated inflammatory markers predict mortality in long-term ischemic stroke-survivors: a population-based prospective study.
Frøyshov HM; Bjørnerem Å; Engstad T; Halvorsen DS
Aging Clin Exp Res; 2017 Jun; 29(3):379-385. PubMed ID: 27146666
[TBL] [Abstract][Full Text] [Related]
13. High-sensitivity CRP is an independent risk factor for all fractures and vertebral fractures in elderly men: the MrOS Sweden study.
Eriksson AL; Movérare-Skrtic S; Ljunggren Ö; Karlsson M; Mellström D; Ohlsson C
J Bone Miner Res; 2014 Feb; 29(2):418-23. PubMed ID: 23857741
[TBL] [Abstract][Full Text] [Related]
14. A Combination of Testosterone and White Blood Cell Count as a Predictive Factor of Overall Survival in Localized Prostate Cancer.
Taussky D; Souliéres D; Azoulay L; Yin H; Bahig H; Bahary JP; Delouya G
Target Oncol; 2017 Oct; 12(5):695-701. PubMed ID: 28712059
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory biomarkers and risk of cancer in 84,000 individuals from the general population.
Allin KH; Bojesen SE; Nordestgaard BG
Int J Cancer; 2016 Oct; 139(7):1493-500. PubMed ID: 27194008
[TBL] [Abstract][Full Text] [Related]
16. The role of inflammation in adjuvant chemotherapy-induced sarcopenia (Izmir Oncology Group (IZOG) study).
Oflazoglu U; Alacacioglu A; Varol U; Kucukzeybek Y; Salman T; Onal HT; Yilmaz HE; Yildiz Y; Taskaynatan H; Saray S; Butun O; Tarhan MO
Support Care Cancer; 2020 Aug; 28(8):3965-3977. PubMed ID: 32335732
[TBL] [Abstract][Full Text] [Related]
17. Markers of low-grade inflammation and soluble cell adhesion molecules in Chinese patients with coronary artery disease.
Fang L; Wei H; Mak KH; Xiong Z; Song J; Wang D; Lim YL; Chatterjee S
Can J Cardiol; 2004 Dec; 20(14):1433-8. PubMed ID: 15614337
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer: results from the ASCENT trial.
Beer TM; Lalani AS; Lee S; Mori M; Eilers KM; Curd JG; Henner WD; Ryan CW; Venner P; Ruether JD; Chi KN;
Cancer; 2008 Jun; 112(11):2377-83. PubMed ID: 18428198
[TBL] [Abstract][Full Text] [Related]
19. Is a single time point C-reactive protein predictive of outcome in peritoneal dialysis patients?
Wang AY; Woo J; Lam CW; Wang M; Sea MM; Lui SF; Li PK; Sanderson J
J Am Soc Nephrol; 2003 Jul; 14(7):1871-9. PubMed ID: 12819248
[TBL] [Abstract][Full Text] [Related]
20. C-reactive protein as a marker of progression of carotid atherosclerosis in subjects with type 2 diabetes mellitus.
Pleskovič A; Letonja MŠ; Vujkovac AC; Nikolajević Starčević J; Gazdikova K; Caprnda M; Gaspar L; Kruzliak P; Petrovič D
Vasa; 2017 May; 46(3):187-192. PubMed ID: 28218562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
